100% Quality Guarantee
PhD-Level Technical Support
Key Features
High Purity - > 95 % as determined by reducing SDS-PAGE.
Recombinant - Engineered for batch-to-batch consistency
Low Endotoxin - <1.0 EU per µg as determined by the LAL method.
Flexible - Lyophilised for long-term stability, easy reconstitution
In Stock 10µg

Human TPP1/CLN2 Recombinant Protein (RPES4815)

TPP1/CLN2 · 10µg

SKU RPES4815
Product Type Recombinant Protein
Species Human
Application Area Research Tool Proteins
Target / Synonyms::Tripeptidyl-Peptidase 1 · TPP-1 · Cell Growth-Inhibiting Gene 1 Protein · Lysosomal Pepstatin-Insensitive Protease · LPIC · Tripeptidyl Aminopeptidase · TPP1 · CLN2 ·GIG1 ·LPIC ·SCAR7 ·TPP-1
€1,224
Ships from Ireland

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human TPP1/CLN2 Recombinant Protein

Tripeptidyl-peptidase 1 (TPP1 / CLN2) is a member of the sedolisin family of serine proteases. The protease functions in the lysosome to cleave N-terminal tripeptides from substrates, and has weaker endopeptidase activity. It is synthesized as a catalytically-inactive enzyme which is activated and auto-proteolyzed upon acidification. TPP1 / CLN2 May act as a non-specific lysosomal peptidase which generates tripeptides from the breakdown products produced by lysosomal proteinases. Defects in TPP1 / CLN2 are the cause of neuronal ceroid lipofuscinosis type 2 (CLN2), a form of neuronal ceroid lipofuscinosis which is associated with the failure to degrade specific neuropeptides and a subunit of ATP synthase in the lysosome. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose